IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 12 di 12
Data di pubblicazione Titolo Autore(i) Tipo File
15-gen-2009 Utilizzo di sangue periferico come fonte alternativa al sangue midollare per il monitoraggio della malattia minima residua nella Leucemia Mieloide Acuta Mazzone, Carla Tesi di dottorato
20-mar-2016 Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial Amadori, S; Suciu, S; Selleslag, D; Aversa, F; Gaidano, G; Musso, M; Annino, L; Venditti, A; Voso, Mt; Mazzone, C; Magro, D; DE FABRITIIS, P; Muus, P; Alimena, G; Mancini, M; Hagemeijer, A; Paoloni, F; Vignetti, M; Fazi, P; Meert, L; Ramadan, S; Willemze, R; de Witte, T; Baron, F Articolo su rivista
1-gen-2019 Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation Niscola, P; Grazia, Cd; Mazzone, C; Tolu, B; De Fabritiis, P; Angelucci, E Articolo su rivista
1-gen-2019 Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy Niscola, P; Noguera, Ni; Catalano, G; Cupelli, L; Fratoni, S; Giovannini, M; Mazzone, C; Neri, B; Scaramucci, L; Trawinska, Mm; de Fabritiis, P; Abruzzese, E Articolo su rivista
1-gen-2020 TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge? Molica, M; Mazzone, C; Niscola, P; de Fabritiis, P Articolo su rivista
1-lug-2020 SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies Molica, M; Mazzone, C; Cordone, I; Pasquale, A; Niscola, P; de Fabritiis, P Articolo su rivista
1-gen-2021 Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatinib Molica, M; Mazzone, C; Cordone, I; Divona, M; Niscola, P; de Fabritiis, P Articolo su rivista
1-giu-2021 New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine Niscola, P; Mazzone, C; Molica, M; de Fabritiis, P Articolo su rivista
28-giu-2021 CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin Molica, M; Perrone, S; Mazzone, C; Niscola, P; Cesini, L; Abruzzese, E; de Fabritiis, P Articolo su rivista
8-giu-2022 CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML Molica, M; Perrone, S; Mazzone, C; Cesini, L; Canichella, M; de Fabritiis, P Articolo su rivista
6-ott-2022 Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience Molica, M; Mazzone, C; Niscola, P; Carmosino, I; Di Veroli, A; De Gregoris, C; Bonanni, F; Perrone, S; Cenfra, N; Fianchi, L; Piccioni, Al; Spadea, A; Luzi, G; Mengarelli, A; Cudillo, L; Maurillo, L; Pagano, L; Breccia, M; Rigacci, L; De Fabritiis, P Articolo su rivista
17-mag-2023 Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient Niscola, P; Mazzone, C; Fratoni, S; Ardu, Nr; Cesini, L; Giovannini, M; Ottone, T; Anemona, L; Voso, Mt; de Fabritiis, P Articolo su rivista
Mostrati risultati da 1 a 12 di 12
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile